The theme of this year's conference is "Clinical Trial Networks and Teams Science: Moving Discoveries to Interventions."

The new Institute for Biomedical Informatics is leading the effort to translate big data into actionable information and leverage the latest technologies to advance biomedical sciences.

The CCTS pilot funding program provides opportunities and resources for innovative, collaborative research relevant to the health challenges and disparities faced by the nation.

With support from a high-impact pilot award from the CCTS, Samy-Claude Elayi and a multidisciplinary group of researchers are trying to understand why a condition presents so differently in family members with the same genetic mutation.

The trial is the first in the world to intra-arterially deliver a single, small dose of bevacizumab, a cancer drug known by the name of Avastin, directly to the area of the brain affected by radiation necrosis.

A new study by University of Kentucky Markey Cancer Center researchers shows that chloroquine – a drug currently used to treat malaria – may be useful in treating patients with metastatic cancers.

Deep Brain Stimulation (DBS) is a surgical procedure used to treat the problems associated with Parkinson’s disease. The procedure involves implanting electrodes into the brain that are connected to a small, pacemaker-like device implanted in the chest

The following is a recap of some of the highlights from 2015-2016 at the University of Kentucky.

President Eli Capilouto explains the values of education, inquiry, and selflessness that guide work at the University of Kentucky.

Gabe Harris has been named the executive director of the University of Kentucky Center for Clinical and Translational Science (CCTS), beginning Jan. 1, 2017.